Search Orphan Drug Designations and Approvals
-
Generic Name: | oral tyrosine kinase inhibitor |
---|---|
Date Designated: | 06/28/2017 |
Orphan Designation: | Treatment of chronic myeloid leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Fusion Pharma, LLC Territory of the Skolkovo innovation center Nobelya St. 7, Moscow Russia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-